Inspire Medical Systems (STU:2DR) Current Ratio: 6.34 (As of Mar. 2026) — 27% Below Median


STU:2DR Inspire Medical Systems Inc STU:2DR
59 GF Score
Price €40.00
GF Value €190.55
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Inspire Medical Systems Current Ratio?

Inspire Medical Systems STU:2DR +4.17% 59 Current Ratio is 6.34 as of Mar. 2026, which is 27% below its 10-year median of 8.66. GuruFocus rates STU:2DR with a GF Score™ of 59/100 and a GF Value™ of €190.55 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 854 Medical Devices & Instruments companies, Inspire Medical Systems ranks better than 84.43% on this metric.

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Inspire Medical Systems's current ratio for the quarter that ended in Mar. 2026 was 6.34.

Inspire Medical Systems has a current ratio of 6.34. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.

The historical rank and industry rank for Inspire Medical Systems's Current Ratio or its related term are showing as below:

STU:2DR' s Current Ratio Range Over the Past 10 Years
Min: 1.68   Med: 8.66   Max: 24.09
Current: 6.34

During the past 11 years, Inspire Medical Systems's highest Current Ratio was 24.09. The lowest was 1.68. And the median was 8.66.

STU:2DR's Current Ratio is ranked better than
84.43% of 854 companies
in the Medical Devices & Instruments industry
Industry Median: 2.475 vs STU:2DR: 6.34

Inspire Medical Systems  (STU:2DR) Current Ratio Explanation

The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.

Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.

The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.

If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.


Inspire Medical Systems Current Ratio Related Terms


Inspire Medical Systems Current Ratio Historical Data

* Premium members only.

The historical data trend for Inspire Medical Systems's Current Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Inspire Medical Systems Current Ratio Chart

Inspire Medical Systems Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Current Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.50 8.66 7.60 7.13 6.08

Inspire Medical Systems Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Current Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.01 6.14 5.29 6.08 6.34

STU:2DR vs ENOV, PRCT, AHCO: Current Ratio Comparison

For the Medical Devices subindustry, Inspire Medical Systems's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Inspire Medical Systems Current Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Inspire Medical Systems's Current Ratio distribution charts can be found below:

* The bar in red indicates where Inspire Medical Systems's Current Ratio falls into.


STU:2DR
59GF Score
Inspire Medical Systems Inc STU:2DR
Current Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Inspire Medical Systems Current Ratio Calculation

The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.

Inspire Medical Systems's Current Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Current Ratio (A: Dec. 2025 )=Total Current Assets (A: Dec. 2025 )/Total Current Liabilities (A: Dec. 2025 )
=498.439/82.031
=6.08

Inspire Medical Systems's Current Ratio for the quarter that ended in Mar. 2026 is calculated as

Current Ratio (Q: Mar. 2026 )=Total Current Assets (Q: Mar. 2026 )/Total Current Liabilities (Q: Mar. 2026 )
=490.298/77.347
=6.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Current Ratio →
What does a Current Ratio of 6.34 mean?
Inspire Medical Systems (STU:2DR) has a Current Ratio of 6.34 as of Mar. 2026. This is 27% below median its historical median of 8.66. Over the past decade, Inspire Medical Systems' Current Ratio has ranged from 1.68 to 24.09. According to the industry distribution chart, Inspire Medical Systems ranks #133 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 15.6%.
Is Inspire Medical Systems' Current Ratio too high?
Inspire Medical Systems' current Current Ratio of 6.34 is 27% below median its 10-year median of 8.66. Over the past 10 years, this metric has ranged from a low of 1.68 to a high of 24.09. The Medical Devices & Instruments industry median Current Ratio is 2.48. Inspire Medical Systems' value of 6.34 is 156.2% above this industry median. Based on the distribution chart, Inspire Medical Systems ranks #133 out of 854 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Inspire Medical Systems has a GF Score™ of 59/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Inspire Medical Systems' Current Ratio compare to ENOV and PRCT?
According to the Medical Devices & Instruments industry distribution chart, Inspire Medical Systems ranks #133 out of 854 companies for Current Ratio. This places Inspire Medical Systems in the top 16% of its industry — outperforming the majority of peers. The industry median Current Ratio is 2.48. Inspire Medical Systems' value of 6.34 is 156.2% above this benchmark. Historically, Inspire Medical Systems' own Current Ratio has ranged from 1.68 to 24.09 over the past decade. While the company's 10-year median is 8.66 vs. the industry median of 2.48, Inspire Medical Systems has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Medical Devices & Instruments company?
The median Current Ratio among Medical Devices & Instruments companies is 2.48, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Inspire Medical Systems's current Current Ratio of 6.34 is 156.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median Current Ratio is 2.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Inspire Medical Systems's current Current Ratio is 6.34, which is 27% below median its own 10-year median of 8.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inspire Medical Systems stock overvalued right now?
Based on GuruFocus' analysis, Inspire Medical Systems (STU:2DR) is currently considered Possible Value Trap. The stock's GF Value™ is €190.55, compared to a current price of €40.00 — trading 79% below its estimated fair value. The current Current Ratio is 6.34, which is 27% below median its 10-year median of 8.66 and 156.2% above the Medical Devices & Instruments industry median of 2.48. Inspire Medical Systems' overall GF Score™ is 59/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Inspire Medical Systems (STU:2DR), the current Current Ratio is 6.34 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Inspire Medical Systems (STU:2DR) Overvalued in 2026?

Based on GuruFocus' analysis, Inspire Medical Systems stock appears to be undervalued. The current stock price of €40.00 is trading 79% below its estimated GF Value™ of €190.55. GuruFocus considers Inspire Medical Systems to be Possible Value Trap.

Key valuation signals for STU:2DR:

  • Current Ratio: 6.34 (27% below median its 10-year median of 8.66)
  • GF Value™: €190.55 vs. price of €40.00 (79% below fair value)
  • GF Score™: 59/100 with 7 warning signs
  • Industry Position: 156.2% above the Medical Devices & Instruments median (#133 of 854)

No single metric tells the full story. See the STU:2DR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Inspire Medical Systems Business Description

Other Exchanges INSP:USA
Address 5500 Wayzata Boulevard, Suite 1600, Golden Valley, MN, USA, 55416
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.
59GF Score

Get the complete analysis for STU:2DR

Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€40.00
Price
€190.55
GF Value